Summit Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Summit Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About SMMT

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). 

CEO
Robert William Duggan
CEORobert William Duggan
Employees
265
Employees265
Headquarters
Miami, Florida
HeadquartersMiami, Florida
Founded
2003
Founded2003
Employees
265
Employees265

SMMT Key Statistics

Market cap
14.38B
Market cap14.38B
Price-Earnings ratio
-11.82
Price-Earnings ratio-11.82
Dividend yield
Dividend yield
Average volume
5.44M
Average volume5.44M
High today
$19.06
High today$19.06
Low today
$18.43
Low today$18.43
Open price
$18.79
Open price$18.79
Volume
526.03K
Volume526.03K
52 Week high
$30.98
52 Week high$30.98
52 Week low
$13.83
52 Week low$13.83

Stock Snapshot

The current Summit Therapeutics(SMMT) stock price is $18.53, with a market capitalization of 14.38B. The stock trades at a price-to-earnings (P/E) ratio of -11.82.

As of 2026-05-13, Summit Therapeutics(SMMT) stock has fluctuated between $18.43 and $19.06. The current price stands at $18.53, placing the stock +0.5% above today's low and -2.8% off the high.

Summit Therapeutics(SMMT) shares are trading with a volume of 526.03K, against a daily average of 5.44M.

In the last year, Summit Therapeutics(SMMT) shares hit a 52-week high of $30.98 and a 52-week low of $13.83.

In the last year, Summit Therapeutics(SMMT) shares hit a 52-week high of $30.98 and a 52-week low of $13.83.

Analyst ratings

72%

of 18 ratings
Buy
72.2%
Hold
22.2%
Sell
5.6%

People also own

Based on the portfolios of people who own SMMT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.